Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis.

Chen W, Li F, He C, Zhu Y, Tan W.

Ir J Med Sci. 2014 Jun;183(2):283-91. doi: 10.1007/s11845-013-1007-x. Epub 2013 Aug 30. Review.

PMID:
23990176
2.

Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study.

Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF.

Hypertension. 2009 Apr;53(4):605-10. doi: 10.1161/HYPERTENSIONAHA.108.122002. Epub 2009 Feb 16.

3.

A possible association between primary aldosteronism and a lower beta-cell function.

Mosso LM, Carvajal CA, Maiz A, Ortiz EH, Castillo CR, Artigas RA, Fardella CE.

J Hypertens. 2007 Oct;25(10):2125-30.

PMID:
17885557
4.

Insulin sensitivity in patients with primary aldosteronism: a follow-up study.

Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi G, Novello M, Favret G, Melis A, Cavarape A, Sechi LA.

J Clin Endocrinol Metab. 2006 Sep;91(9):3457-63. Epub 2006 Jul 5.

PMID:
16822818
5.

Evaluation of insulin sensitivity and secretion in primary aldosteronism.

Watanabe D, Yatabe M, Ichihara A.

Clin Exp Hypertens. 2016;38(7):613-617. Epub 2016 Sep 26.

PMID:
27669369
6.

Glucose Metabolism in Primary Aldosteronism.

Remde H, Hanslik G, Rayes N, Quinkler M.

Horm Metab Res. 2015 Dec;47(13):987-93. doi: 10.1055/s-0035-1565208. Epub 2015 Dec 14. Review.

PMID:
26667801
7.

[Incidence of metabolic disorders in patients with essential hypertension and patients with primary aldosteronism].

Gong YC, Guo RM, Chen SX, Chu SL, Guo JZ, Zhu DL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Feb;36(2):128-31. Chinese.

PMID:
19099949
8.

Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.

Fischer E, Adolf C, Pallauf A, Then C, Bidlingmaier M, Beuschlein F, Seissler J, Reincke M.

J Clin Endocrinol Metab. 2013 Jun;98(6):2513-20. doi: 10.1210/jc.2012-3934. Epub 2013 Mar 28.

PMID:
23539730
9.

[Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].

Deng YJ, Zhang SL, Liu PM, Mai LF, Tang JY, Yan L.

Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Sep 24;44(9):743-749. doi: 10.3760/cma.j.issn.0253-3758.2016.09.003. Chinese.

PMID:
27667270
10.

Glucose metabolism in patients with essential hypertension.

García-Puig J, Ruilope LM, Luque M, Fernández J, Ortega R, Dal-Ré R; AVANT Study Group Investigators.

Am J Med. 2006 Apr;119(4):318-26.

PMID:
16564774
11.

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, Rabbia F, Federspil G, Mulatero P.

J Clin Endocrinol Metab. 2006 Feb;91(2):454-9. Epub 2005 Nov 15.

PMID:
16291704
12.

Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.

Ronconi V, Turchi F, Rilli S, Di Mattia D, Agostinelli L, Boscaro M, Giacchetti G.

Nutr Metab Cardiovasc Dis. 2010 Feb;20(2):93-100. doi: 10.1016/j.numecd.2009.03.007. Epub 2009 May 29.

PMID:
19481913
13.

Prevalence of primary aldosteronism in hypertensive subjects with hyperglycemia.

Li N, Wang M, Wang H, Zhang D, Wang X, Zu F, Chang G, Zhou K.

Clin Exp Hypertens. 2013;35(3):175-82. doi: 10.3109/10641963.2012.712175. Epub 2012 Aug 22.

PMID:
22913631
14.

A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.

Yang Y, Wei RB, Xing Y, Tang L, Zheng XY, Wang ZC, Gao YW, Li MX, Chen XM.

Metabolism. 2013 Dec;62(12):1858-66. doi: 10.1016/j.metabol.2013.08.008. Epub 2013 Sep 16. Review.

PMID:
24050270
15.

Adiponectin and insulin sensitivity in primary aldosteronism.

Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R, Veglio F, Mulatero P.

Am J Hypertens. 2007 Aug;20(8):855-61.

PMID:
17679033
16.

Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.

Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D.

Pituitary. 2014 Feb;17(1):81-9. doi: 10.1007/s11102-013-0471-7.

PMID:
23446424
17.
18.

Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women--a meta-analysis.

Zhang YB, Chen WH, Guo JJ, Fu ZH, Yi C, Zhang M, Na XL.

Nutrition. 2013 Jan;29(1):8-14. doi: 10.1016/j.nut.2012.03.019. Epub 2012 Aug 2. Review.

PMID:
22858192
19.

The effect of aldosterone on glucose metabolism.

Corry DB, Tuck ML.

Curr Hypertens Rep. 2003 Apr;5(2):106-9. Review.

PMID:
12642008
20.

[Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].

Tang XF, Li H, Wang JG, Chu SL, Guo JZ, Zhu DL.

Zhonghua Nei Ke Za Zhi. 2004 Oct;43(10):735-9. Chinese.

PMID:
15631823

Supplemental Content

Support Center